Heather Wakelee
An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
This large, non-randomized observational study is being conducted to provide data about the impact of ethnic origin on outcomes and resource utilization during the 2nd line treatment of non-small cell lung cancer in a routine medical care setting.
Recruiting Status:
RecruitingStanford Recruiting Status:
RecruitingCondition(s):
Intervention(s):
- Drug: Pemetrexed
Phase:
N/AEligibility
Ages Eligible for Study:
18 years to Any AgeGenders Eligible for Study:
Male and FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
- NSCLC (any histologic type)
- Stage IIIB or IV disease
- Should have had 1 line of chemotherapy for Metastatic disease
- Adequate hematologic, hepatic and renal function
- Measurable or evaluable disease
Key Exclusion Criteria:
Pregnant or lactating females
Additional Study Details
Official Title:
Observational Study Description H3E-US-B001 Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients being Treated Second Line with Pemetrexed - An Observational StudyAnticipated start date:
11/6/2008Lead Sponsor:
Eli Lilly and CompanyInvestigator(s):
Study Type:
ObservationalPurpose:
NOTNEEDEDDuration:
LongitudinalSelection:
Defined PopulationTiming:
ProspectiveTotal Number to be Enrolled:
1000Total Number to be Enrolled at Stanford:
10More Information
Secondary ID(s):
- 98559
- H3E-US-B001
- LUN0025
- NCT00497770
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.
This listing was last updated:
6/5/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help